Review found differences in estimated treatments for chlamydia and gonorrhea despite CDC guidelines

Published Date: 02 Mar 2023

A review of chlamydia and gonorrhea prevention studies conducted by the Regenstrief Institute found that rates of presumptive treatment (antibiotics before diagnosis) varied.

Read Full News

Latest News

Moderna's MRNA Flu Vaccine Outperforms Standard Shot in Late-stage Trial

Moderna's mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of more than 40,000 adults aged ⁠50 and older,...

CDC Says It Is Monitoring US Travelers on Cruise Ship After Hantavirus Outbreak

The United States is closely monitoring the situation with U.S. travelers on board the luxury cruise ship that was ⁠hit by a hantavirus outbreak, the Centers for Disease...

US FDA Blocked Publication of COVID, Shingles Vaccine Safety Studies

Officials at the U.S. Food and Drug Administration blocked the publication of several studies supporting the ⁠safety of widely used vaccines against COVID-19 and shingles, a...

New Surveillance Study Supports Maternal RSV Vaccine Safety

Early data keep hypertension concerns on the radar, but more robust research shows no increased risk.

Young Age, Lower BMI May Predict HIV Treatment Failure

Younger age, lower BMI for age, and lower CD4% at antiretroviral therapy initiation may predict treatment failure in children living with HIV.

California's Highest Court Leans Toward Gilead in Considering Drugmakers' 'duty to Innovate'

California's highest court on Wednesday appeared skeptical of requiring Gilead Sciences and other manufacturers of drugs that are considered safe to try developing drugs...

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Latest News

Moderna's mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of more than 40,000 adults aged ⁠50 and older,...

The United States is closely monitoring the situation with U.S. travelers on board the luxury cruise ship that was ⁠hit by a hantavirus outbreak, the Centers for Disease...

Officials at the U.S. Food and Drug Administration blocked the publication of several studies supporting the ⁠safety of widely used vaccines against COVID-19 and shingles, a...

Early data keep hypertension concerns on the radar, but more robust research shows no increased risk.

Younger age, lower BMI for age, and lower CD4% at antiretroviral therapy initiation may predict treatment failure in children living with HIV.

California's highest court on Wednesday appeared skeptical of requiring Gilead Sciences and other manufacturers of drugs that are considered safe to try developing drugs...

News All Time

Moderna Starts Late-stage Trial of Bird Flu Vaccine in US, UK

Moderna said on Tuesday it had started a late-stage study of its experimental bird flu vaccine ⁠in the U.S. and the UK, marking the first time a pandemic bird flu vaccine...

US CDC Will Not Publish Report Showing COVID Vaccine Effectiveness

A report showing the efficacy of COVID-19 vaccines has been blocked from being published in the U.S. ⁠Centers for Disease Control and Prevention's flagship scientific...

Long COVID May Persist as Diagnostic Gaps Remain

Long COVID reflects persistent biological dysfunction with multisystem involvement, while gaps in biomarkers and treatment continue to complicate diagnosis and clinical care.

Deadly Meningitis Spreads as Sudanese Refugees Pack Chad Camps, MSF Says

Cases of deadly meningitis are surging in eastern Chad, killing ⁠nearly 12% of children who catch it in an area housing hundreds of thousands of ⁠war refugees from...

Moderna Wins EU Approval for Combined Flu, COVID Shot for Older Adults

Moderna said on Tuesday the European Commission had approved its combination vaccine for ⁠the prevention of influenza and COVID-19 in adults 50 years of age and...

US Aid Cuts Undermine HIV Prevention in South Africa, Report Finds

U.S. funding cuts to South Africa have dismantled HIV prevention programmes just as they are needed to support ⁠the roll-out of the new prevention drug lenacapavir, a report...

US Figures Suggest HIV Aid Was Maintained; but Data Show Drops in Testing, Diagnoses

The U.S. State Department on Friday said it had supported HIV treatment for 20.6 million people as of September last year, including 3 million people whose care was...

Integrase Inhibitors May Raise Cardiometabolic Risk in HIV

Switching to integrase strand transfer inhibitors may raise cardiometabolic risk in people living with HIV on stable antiretroviral therapy and with a low-to-moderate cardiovascular risk.

Funding Cuts Challenge Malaria Vaccination Initiatives

Fewer resources through Gavi, the Vaccine Alliance, may limit vaccine administration at the local level.

Global Fund Expands Commitment to Improve Access to HIV Drug

The U.S. and the Global Fund to Fight AIDS, Tuberculosis and Malaria are stepping up efforts to ⁠broaden access to Gilead's HIV prevention drug, with a goal of reaching 3...

HIV Treatment May Move Beyond Daily Pills With Injectables

Monthly injectable HIV therapy shows lower treatment failure than oral regimens in individuals with adherence challenges.

Trump Officials Consider Ophthalmologist Hemmati for Top Vaccine Post, Reports Say

The Trump administration is considering appointing Houman Hemmati, an ⁠ophthalmologist and a frequent Fox News guest, to lead the FDA's Center ⁠for Biologics Evaluation and...

Should US Policies Qualify as a Global Health Emergency?

Debate is growing over whether national policy decisions can meet the criteria for global health emergencies, as projections suggest major setbacks in infectious disease control.

US CDC Delays Publishing Report Showing COVID Vaccine Benefits, WaPo Reports

The acting director of ⁠the Centers for Disease Control ⁠and Prevention has delayed publication ⁠of a ‌CDC report showing the COVID-19 vaccine cut the likelihood of...

US FDA Approves Waters' At‑home Cervical Cancer Screening Kit

Lab equipment maker Waters said on Wednesday the U.S. Food and Drug ⁠Administration has cleared its at-home cervical cancer screening kit for use with an ⁠approved HPV test,...

On-Site Hepatitis C Care Boosts Treatment Uptake

On-site hepatitis C virus testing and treatment with peer support at opioid treatment programs boosts access to curative therapy and sharply increases treatment initiation.